Alternative pathway androgen biosynthesis and human fetal female virilization

Nicole Reisch, Angela E Taylor, Edson F Nogueira, Daniel J Asby, Vivek Dhir, Andrew Berry, Nils Krone, Richard J Auchus, Cedric H L Shackleton, Neil A Hanley, Wiebke Arlt

Research output: Contribution to journalArticle (Academic Journal)

28 Downloads (Pure)

Abstract

Androgen biosynthesis in the human fetus proceeds through the adrenal sex steroid precursor dehydroepiandrosterone, which is converted to testosterone in the gonads, followed by further activation to 5α-dihydrotestosterone in genital skin, thereby facilitating male external genital differentiation. Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency results in disrupted dehydroepiandrosterone biosynthesis, explaining undervirilization in affected boys. However, many affected girls are born virilized, despite low circulating androgens. We hypothesized that this is due to a prenatally active, alternative androgen biosynthesis pathway from 17α-hydroxyprogesterone to 5α-dihydrotestosterone, which bypasses dehydroepiandrosterone and testosterone, with increased activity in congenital adrenal hyperplasia variants associated with 17α-hydroxyprogesterone accumulation. Here we employ explant cultures of human fetal organs (adrenals, gonads, genital skin) from the major period of sexual differentiation and show that alternative pathway androgen biosynthesis is active in the fetus, as assessed by liquid chromatography-tandem mass spectrometry. We found androgen receptor expression in male and female genital skin using immunohistochemistry and demonstrated that both 5α-dihydrotestosterone and adrenal explant culture supernatant induce nuclear translocation of the androgen receptor in female genital skin primary cultures. Analyzing urinary steroid excretion by gas chromatography-mass spectrometry, we show that neonates with P450 oxidoreductase deficiency produce androgens through the alternative androgen pathway during the first weeks of life. We provide quantitative in vitro evidence that the corresponding P450 oxidoreductase mutations predominantly support alternative pathway androgen biosynthesis. These results indicate a key role of alternative pathway androgen biosynthesis in the prenatal virilization of girls affected by congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.

Original languageEnglish
Pages (from-to)22294-22299
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume116
Issue number44
Early online date14 Oct 2019
DOIs
Publication statusPublished - 29 Oct 2019

Keywords

  • fetal androgen biosynthesis
  • congenital adrenal hyperplasia
  • alternative androgen pathway
  • 5α-dihydrotestosterone
  • human sexual differentiation

Fingerprint Dive into the research topics of 'Alternative pathway androgen biosynthesis and human fetal female virilization'. Together they form a unique fingerprint.

  • Cite this

    Reisch, N., Taylor, A. E., Nogueira, E. F., Asby, D. J., Dhir, V., Berry, A., Krone, N., Auchus, R. J., Shackleton, C. H. L., Hanley, N. A., & Arlt, W. (2019). Alternative pathway androgen biosynthesis and human fetal female virilization. Proceedings of the National Academy of Sciences of the United States of America, 116(44), 22294-22299. https://doi.org/10.1073/pnas.1906623116